Soluble LOX-1: A Novel Biomarker in Patients With Coronary Artery Disease, Stroke, and Acute Aortic Dissection?

被引：43
|
作者：
Hofmann, Anja [1 ,2 ]
Brunssen, Coy [1 ]
Wolk, Steffen [2 ]
Reeps, Christian [2 ]
Morawietz, Henning [1 ,3 ]
机构：
[1] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Med 3, Div Vasc Endothelium & Microcirculat, Fetscherstr 74, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Med Fac Carl Gustav Carus, Div Vasc & Endovasc Surg, Dept Visceral Thorac & Vasc Surg, Dresden, Germany
[3] Tech Univ Dresden, Univ Hosp Carl Gustav Carus Dresden, Fetscherstr 74, D-01307 Dresden, Germany
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2020年 / 9卷 / 01期
关键词：
aortic dissection; coronary artery disease; LOX-1; myocardial infarction; stroke; LOW-DENSITY-LIPOPROTEIN; OXIDIZED LDL RECEPTOR-1; RENIN-ANGIOTENSIN SYSTEM; MYOCARDIAL-INFARCTION; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; TROPONIN-T; EXPRESSION; MARKER; ATHEROSCLEROSIS;
D O I：
10.1161/JAHA.119.013803
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：13
相关论文
共 50 条
  • [1] Circulatory soluble LOX-1 is a novel predictor for coronary artery disease patients
    Sheikh, Md Sayed Ali
    CARDIOVASCULAR JOURNAL OF AFRICA, 2023, 34 (02) : 104 - 108
  • [2] The LOX-1 3'UTR188CT polymorphism and coronary artery disease in Turkish patients
    Kurnaz, Ozlem
    Akadam-Teker, A. Basak
    Yilmaz-Aydogan, Hulya
    Tekeli, Atike
    Isbir, Turgay
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (04) : 4351 - 4358
  • [3] The LOX-1 scavenger receptor and its implication in coronary artery disease
    Pant, Sadip
    Deshmukh, Abhishek
    Mehta, J. L.
    CLINICAL LIPIDOLOGY, 2012, 7 (03) : 271 - 273
  • [4] LOX-1, a new marker of risk and prognosis in coronary artery disease?
    Lubrano, Valter
    Balzan, Silvana
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 383 (1-2) : 223 - 230
  • [5] LOX-1, a new marker of risk and prognosis in coronary artery disease?
    Valter Lubrano
    Silvana Balzan
    Molecular and Cellular Biochemistry, 2013, 383 : 223 - 230
  • [6] Is LOX-1 K167N Polymorphism Protective for Coronary Artery Disease?
    Kurnaz, Oezlem
    Aydogan, Huelya Yilmaz
    Isbir, C. Selim
    Tekeli, Atike
    Isbir, Turgay
    IN VIVO, 2009, 23 (06): : 969 - 973
  • [7] LOX-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes
    Fukui, Michiaki
    Tanaka, Muhei
    Senmaru, Takafumi
    Nakanishi, Mamoru
    Mukai, Jun
    Ohki, Makoto
    Asano, Mai
    Yamazaki, Masahiro
    Hasegawa, Goji
    Nakamura, Naoto
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (07): : 935 - 938
  • [8] Novel Insights into the Link Between Myeloperoxidase Modified LDL, LOX-1, and Neuroserpin in Stroke
    El-Hajjar, Layal
    Miranda, Elena
    El-Sabban, Marwan
    Daher, Jalil
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (12)
  • [9] Associations of Tissue and Soluble LOX-1 with Human Abdominal Aortic Aneurysm
    Hofmann, Anja
    Khorzom, Yazan
    Klimova, Anna
    Wolk, Steffen
    Busch, Albert
    Sabarstinski, Pamela
    Mueglich, Margarete
    Egorov, Dmitry
    Kopaliani, Irakli
    Poitz, David M.
    Kapalla, Marvin
    Hamann, Bianca
    Frank, Frieda
    Jaenichen, Christian
    Brunssen, Coy
    Morawietz, Henning
    Reeps, Christian
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (14):
  • [10] Serum LOX-1 is a novel prognostic biomarker of colorectal cancer
    Nakashima-Nakasuga, Chiyo
    Hazama, Shoichi
    Suzuki, Nobuaki
    Nakagami, Yuki
    Xu, Ming
    Yoshida, Shin
    Tomochika, Shinobu
    Fujiwara, Nobuyuki
    Matsukuma, Satoshi
    Matsui, Hiroto
    Tokumitsu, Yukio
    Kanekiyo, Shinsuke
    Shindo, Yoshitaro
    Maeda, Noriko
    Tsunedomi, Ryouichi
    Iida, Michihisa
    Takeda, Shigeru
    Yoshino, Shigefumi
    Ueno, Tomio
    Hamamoto, Yoshihiko
    Ogihara, Hiroyuki
    Hoshii, Yoshinobu
    Nagano, Hiroaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (07) : 1308 - 1317
12345